Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 30, 2013

PAINTERS DISTRICT COUNCIL NO. 30 HEALTH & WELFARE FUND v. ABBVIE INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 01, 2013

    AbbVie, Teva Hit With 2 More Niaspan Pay-For-Delay Suits

    AbbVie Inc. and Teva Pharmaceutical Industries Ltd. were hit Tuesday with a pair of putative antitrust class actions challenging a pay-for-delay deal that allegedly harmed consumers by keeping a generic version of AbbVie's cholesterol drug Niaspan off the market.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login